BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

BBIO

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-24Shares Purchased (TTM):0Shares Sold (TTM):1,429,125

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:186,080,680Shares Outstanding:194,789,897Institutional Ownership Pct.:95.53%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
One Point Seven Five Percentage Convertible Senior…	-	-	-	559	5	-	-	-	-	-	-	-
Two Point Two Five Percentage Convertible Senior N…	-	-	-	1	739	748	-0	0	0	737	0	0
Two Point Five Zero Percentage Convertible Senior …	-	-	-	-4	550	34	-0	0	0	543	0	0
A2033 Convertible Senior Notes	620	-	-	-	0	-	-	-	-	-	-	-
A2031 Convertible Senior Notes	565	565	564	-	575	0	-	-	-	-	-	-
A2029 Convertible Senior Notes	741	741	740	-	0	739	0	-	-	-	-	-
A2027 Convertible Senior Notes	547	547	547	-	0	545	0	-	-	-	-	-
Term Loan	-	0	0	-	-	437	-	-	-	-	-	-
Equity Securities Fv Ni	-	-	-	-	-	0	0	0	0	59	38	50
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	880	570	643	749	541	681	266	408	475	376	505	302
Receivables Long Term Contracts Or Programs	-	-	-	-	-	-	0	1	235	2	5	9
Restricted Cash Current	-	1	-	-	-	0	139	139	0	17	17	20
Available For Sale Securities Debt Securities Curr…	60	17	3	8	-	0	-	40	44	0	0	31
Accounts Receivable Net Current	205	139	117	77	115	5	-	-	-	2	-	-
Inventory Net	33	27	25	18	4	0	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	63	44	52	60	35	35	38	28	28	24	23	21
Assets Current	1,241	798	839	912	695	721	445	616	783	478	588	433
Investments In Affiliates Subsidiaries Associates …	-	-	92	108	128	144	160	117	-	0	-	-
Equity Method Investments	62	80	-	-	-	144	-	-	-	-	-	-
Property Plant And Equipment Net	5	5	6	6	7	7	9	10	11	12	12	13
Operating Lease Right Of Use Asset	17	8	7	6	7	6	6	7	8	8	9	10
Intangible Assets Net Excluding Goodwill	27	28	29	30	28	24	25	25	26	26	27	28
Other Assets Noncurrent	19	17	26	18	17	18	20	19	21	23	19	20
Assets	1,371	936	998	1,080	882	919	665	794	849	546	655	504
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	29	36	19	26	28	10	13	18	5	11	4	4
Employee Related Liabilities Current	39	77	56	37	33	58	44	29	32	57	34	29
Operating Lease Liability Current	4	6	5	5	5	5	5	5	5	4	4	4
Deferred Revenue Current	-	-	-	11	12	15	12	15	14	6	7	6
Contract With Customer Liability Current	6	7	9	-	-	15	-	-	-	-	-	-
Other Liabilities Current	136	120	93	66	41	33	-	-	-	-	-	-
Liabilities Current	816	288	217	176	152	154	139	134	141	144	106	110
Long Term Debt Noncurrent	-	-	-	0	0	437	436	435	435	446	442	440
Operating Lease Liability Noncurrent	14	4	3	4	5	5	6	7	8	9	10	11
Deferred Revenue Noncurrent	-	-	-	15	18	17	19	17	20	4	-	-
Contract With Customer Liability Noncurrent	12	13	13	-	-	17	-	-	-	-	-	-
Other Liabilities Noncurrent	0	0	1	1	0	0	0	0	1	6	12	13
Liabilities	3,640	3,013	2,921	2,859	2,520	2,377	1,883	1,876	1,886	1,889	1,849	1,853
Stockholders Equity
Preferred Stock Value	0	0	0	-	0	0	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	-	-	-	-323	-323	-275	-275	-275	-275	-275	-275	-275
Treasury Stock Common Value	-406	-323	-323	-	-	-275	-	-	-	-	-	-
Additional Paid In Capital	2,112	2,058	2,018	1,981	1,938	1,903	1,876	1,851	1,821	1,481	1,460	1,128
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	0	0	0	0	-0	0	0	0	0
Retained Earnings Accumulated Deficit	-3,985	-3,821	-3,628	-3,446	-3,264	-3,096	-2,831	-2,669	-2,596	-2,561	-2,392	-2,215
Stockholders Equity	-2,268	-2,087	-1,933	-1,788	-1,638	-1,468	-1,230	-1,093	-1,050	-1,354	-1,195	-1,362
Minority Interest	10	11	10	10	10	10	11	11	12	11	12	12
Liabilities And Stockholders Equity	1,371	936	998	1,080	882	919	665	794	849	546	655	504
Related Party	4	2	2	-	-	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	204	202	200	199	197	196	195	194	193	181	180	168
Shares Outstanding	196	195	193	191	190	190	189	188	187	175	174	161
Treasury Stock Common Shares	9	8	8	8	8	6	6	6	6	6	6	6

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.76%	4.14%	22.95%	-	-	-	-	-	-	-	-	-
2025	-8.46%	14.58%	27.70%	5.18%	1.71%	10.26%	2.24%	14.53%	14.47%	0.34%	12.36%	-3.19%
2024	0.72%	-1.37%	-5.59%	-3.32%	2.14%	-0.61%	16.94%	14.22%	38.95%	-10.42%	-7.87%	-7.16%
2023	-	-	-	-7.54%	-15.05%	-23.46%	9.88%	52.53%	36.11%	-17.98%	-20.15%	-13.39%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.52	2.77	3.88	5.19	4.57	4.67	3.19	4.59	5.54	3.32	5.54	3.93
Quick Ratio	1.40	2.52	3.52	4.74	4.31	4.44	2.92	4.37	5.34	3.15	5.33	3.74
Working Capital	424.93M	509.78M	622.78M	736.42M	543.07M	566.29M	305.36M	481.87M	641.95M	333.75M	481.61M	322.76M
Leverage & Debt
Debt to Equity	-1.60	-1.45	-1.51	-1.60	-1.54	-1.63	-1.53	-1.72	-1.80	-1.41	-1.55	-1.36
Interest Coverage TTM	-6.84	-6.39	-6.85	-6.54	-8.15	-6.52	-6.07	-5.87	-5.68	-7.47	-6.90	-6.59
Debt Ratio	2.65	3.22	2.93	2.65	2.86	2.59	2.83	2.36	2.22	3.46	2.82	3.68
Efficiency & Turnover
Asset Turnover TTM	0.51	0.54	0.43	0.25	0.15	0.30	0.33	0.34	0.30	0.02	0.01	0.01
Days Sales Outstanding TTM	100.85	52.40	120.21	118.98	330.19	5.32	-	-	-	68.70	-	-
Receivables Turnover TTM	3.62	6.97	3.04	3.07	1.11	68.56	-	-	-	5.31	-	-
Per Share Metrics
Diluted EPS TTM	-3.73	-3.83	-4.16	-4.08	-3.52	-2.88	-2.36	-2.44	-3.02	-3.95	-3.79	-3.61
Free Cash Flow Per Share TTM	-2.29	-2.34	-3.06	-3.45	-2.64	-2.80	-2.40	-2.22	-3.39	-3.25	-3.05	-3.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	95.13%	95.82%	95.78%	96.19%	95.35%	98.25%	98.90%	98.91%	98.91%	73.71%	59.24%	29.80%
Operating Profit Margin TTM	-90.52%	-104.25%	-172.39%	-278.37%	-547.57%	-267.22%	-249.98%	-232.88%	-219.98%	-6,528.75%	-5,931.12%	-9,349.96%
Net Profit Margin TTM	-125.42%	-145.98%	-225.59%	-329.68%	-525.22%	-241.44%	-203.94%	-208.49%	-246.67%	-6,913.92%	-6,560.01%	-10,199.44%
Growth Metrics
Net Revenue Growth (1Y)	355.17%	126.26%	62.46%	7.62%	-41.71%	2,285.27%	2,209.77%	3,761.22%	181.05%	-88.02%	-89.37%	-93.74%
Net Income Growth (1Y)	8.69%	36.80%	79.71%	70.17%	24.11%	-16.70%	-28.19%	-21.07%	27.33%	32.71%	23.32%	10.21%
EPS Growth (1Y)	6.10%	32.91%	76.58%	67.55%	16.64%	-27.13%	-37.79%	-32.45%	8.76%	20.23%	11.72%	0.70%
Valuation Metrics
P/E TTM	-19.89	-19.99	-12.49	-10.58	-9.82	-9.53	-10.81	-10.40	-10.25	-10.22	-6.96	-4.77
P/B TTM	-6.38	-7.06	-5.15	-4.60	-4.01	-3.50	-3.90	-4.35	-5.26	-4.89	-3.60	-2.03
P/S TTM	24.94	29.18	28.17	34.89	51.59	23.01	22.04	21.68	25.28	706.43	456.77	486.56
Market Cap	14.47B	14.65B	9.96B	8.23B	6.57B	5.11B	4.80B	4.75B	5.53B	6.57B	4.31B	2.76B
Enterprise Value	13.58B	14.08B	9.32B	7.48B	6.03B	4.86B	4.83B	4.78B	5.48B	6.62B	4.22B	2.90B
Calculated Values
Free Cash Flow TTM	-445.12M	-448.60M	-587.52M	-658.18M	-502.26M	-521.66M	-451.54M	-416.49M	-604.92M	-529.03M	-497.82M	-488.08M
Net Debt	-882.02M	-572.14M	-642.95M	-751.10M	-542.74M	-243.76M	28.35M	27.49M	-42.78M	51.71M	-82.42M	138.06M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-24Sale

Owner: Cook, Jennifer E.

Title: -

Shares: 37,167

Price/Share: $70.00

Value: $2,601,690.00

Shares Owned: 8,383

Relationship: Director

Ownership: Direct

2026-06-23Sale

Owner: Valantine, Hannah

Title: -

Shares: 2,196

Price/Share: $68.57

Value: $150,579.72

Shares Owned: 9,259

Relationship: Director

Ownership: Direct

2026-06-15Sale

Owner: Cook, Jennifer E.

Title: -

Shares: 90,240

Price/Share: $66.88

Value: $6,035,251.20

Shares Owned: 6,589

Relationship: Director

Ownership: Direct

2026-06-05Sale

Owner: Kumar, Neil

Title: Chief Executive Officer

Shares: 40,000

Price/Share: $68.01

Value: $2,720,400.00

Shares Owned: 515,686

Relationship: Director,Officer

Ownership: Indirect

2026-05-21Sale

Owner: Kumar, Neil

Title: Chief Executive Officer

Shares: 26,103

Price/Share: $69.30

Value: $1,808,937.90

Shares Owned: 243,327

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-24	Cook, Jennifer E.	Director	-	Direct	Sale	37,167	70.00	$2,601,690.00	8,383	4
2026-06-23	Valantine, Hannah	Director	-	Direct	Sale	2,196	68.57	$150,579.72	9,259	4
2026-06-15	Cook, Jennifer E.	Director	-	Direct	Sale	90,240	66.88	$6,035,251.20	6,589	4
2026-06-05	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	68.01	$2,720,400.00	515,686	4
2026-05-21	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	26,103	69.30	$1,808,937.90	243,327	4
2026-05-18	Trimarchi, Thomas	Officer	President and CFO	Direct	Sale	13,651	65.38	$892,502.38	359,194	4
2026-05-15	Scott, Randal W.	Director	-	Direct	Sale	10,000	67.89	$678,900.00	11,589	4
2026-05-08	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	67.45	$2,698,000.00	555,686	4
2026-04-30	Apuli, Maricel	Officer	Chief Accounting Officer	Direct	Sale	2,000	71.58	$143,160.00	134,115	4
2026-04-10	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	74.60	$2,984,000.00	595,686	4
2026-03-13	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	68.80	$2,752,000.00	635,686	4
2026-03-10	Valantine, Hannah	Director	-	Direct	Sale	8,671	72.00	$624,312.00	7,465	4
2026-03-04	Ellis, Andrea	Director	-	Direct	Sale	64,921	64.87	$4,211,425.27	18,589	4
2026-02-27	Valantine, Hannah	Director	-	Direct	Sale	25,484	67.46	$1,719,150.64	7,465	4
2026-02-26	Apuli, Maricel	Officer	Chief Accounting Officer	Direct	Sale	2,000	66.00	$132,000.00	121,945	4
2026-02-19	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	28,053	71.97	$2,018,974.41	234,451	4
2026-02-17	Apuli, Maricel	Officer	Chief Accounting Officer	Direct	Sale	510	74.31	$37,898.10	123,945	4
2026-02-17	Trimarchi, Thomas	Officer	President and CFO	Direct	Sale	13,600	75.04	$1,020,544.00	336,585	4
2026-02-17	Scott, Randal W.	Director	-	Direct	Sale	10,000	75.28	$752,800.00	11,589	4
2026-02-11	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	72.01	$2,880,400.00	675,686	4
2026-01-09	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	77.00	$3,080,000.00	715,686	4
2025-12-15	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	30,011	74.92	$2,248,424.12	228,776	4
2025-12-08	Apuli, Maricel	Officer	Chief Accounting Officer	Direct	Sale	2,000	74.26	$148,520.00	130,297	4
2025-12-05	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	73.40	$2,936,000.00	755,686	4
2025-11-20	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	26,156	65.86	$1,722,634.16	228,776	4
2025-11-18	Lo, Andrew	Director	-	Indirect	Sale	55,000	65.64	$3,610,200.00	50,583	4
2025-11-17	Trimarchi, Thomas	Officer	President and CFO	Direct	Sale	16,934	66.52	$1,126,449.68	382,830	4
2025-11-17	Scott, Randal W.	Director	-	Direct	Sale	10,000	66.57	$665,700.00	11,589	4
2025-11-12	Valantine, Hannah	Director	-	Direct	Sale	25,484	66.07	$1,683,727.88	7,465	4
2025-11-07	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	61.94	$2,477,600.00	795,686	4
2025-11-06	Daniels, Ronald J	Director	-	Direct	Sale	61,031	63.72	$3,888,895.32	16,991	4
2025-10-29	Mccormick, Frank	Director	-	Indirect	Sale	198,359	67.39	$13,367,413.01	679,979	4
2025-10-27	Mccormick, Frank	Director	-	Indirect	Sale	1,641	65.00	$106,665.00	878,338	4
2025-10-09	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	54.80	$2,192,000.00	835,686	4
2025-09-05	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	52.97	$2,118,800.00	875,686	4
2025-09-05	Mccormick, Frank	Director	-	Direct	Sale	74,000	53.16	$3,933,840.00	83,275	4
2025-08-21	Trimarchi, Thomas	Officer	President and CFO	Direct	Sale	42,237	49.48	$2,089,886.76	421,081	4
2025-08-20	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	26,156	49.03	$1,282,428.68	223,090	4
2025-08-18	Trimarchi, Thomas	Officer	President and CFO	Direct	Sale	17,353	50.54	$877,020.62	463,318	4
2025-08-11	Homcy, Charles J	Director	-	Direct	Sale	50,000	48.00	$2,400,000.00	916,674	4
2025-08-08	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	46.30	$1,852,000.00	915,686	4
2025-08-07	Apuli, Maricel	Officer	Chief Accounting Officer	Direct	Sale	1,000	45.44	$45,440.00	141,859	4
2025-08-05	Ellis, Andrea	Director	-	Direct	Sale	17,167	49.00	$841,183.00	18,589	4
2025-07-02	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	40,000	42.73	$1,709,200.00	955,686	4
2025-06-27	Halvorsen, Ole Andreas, V…	TenPercentOwner	-	Indirect	Sale	3,500,000	44.00	$154,000,000.00	18,555,375	4
2025-06-26	Valantine, Hannah	Director	-	Direct	Sale	2,418	44.06	$106,537.08	7,465	4
2025-06-24	Mccormick, Frank	Director	-	Indirect	Sale	100,000	44.23	$4,423,000.00	879,979	4
2025-06-10	Valantine, Hannah	Director	-	Direct	Sale	4,292	40.00	$171,680.00	1,764	4
2025-05-20	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	75,000	33.40	$2,505,000.00	4,798,447	4
2025-05-12	Kravis, Henry R, Kkr Mana…	TenPercentOwner	-	Indirect	Sale	6,000,000	34.20	$205,200,000.00	13,260,971	4
2025-05-02	Lo, Andrew	Director	-	Indirect	Sale	100,000	38.50	$3,850,000.00	105,583	4
2025-05-02	Apuli, Maricel	Officer	Chief Accounting Officer	Direct	Sale	1,026	38.51	$39,511.26	147,639	4
2025-04-22	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	75,000	34.11	$2,558,250.00	4,873,447	4
2025-04-14	Ellis, Andrea	Director	-	Direct	Sale	10,000	35.00	$350,000.00	12,000	4
2025-04-01	Ellis, Andrea	Director	-	Direct	Sale	30,000	34.05	$1,021,500.00	12,000	4
2025-03-25	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	75,000	36.87	$2,765,250.00	4,948,447	4
2025-03-06	Valantine, Hannah	Director	-	Direct	Sale	12,875	32.58	$419,467.50	1,764	4
2025-03-05	Kkr, Group Holdings Corp.…	TenPercentOwner	-	Indirect	Sale	6,000,000	32.96	$197,760,000.00	19,260,971	4
2025-02-25	Stephenson, Brian C	Officer	CFO and Treasurer	Direct	Sale	8,500	33.68	$286,280.00	102,464	4
2025-02-25	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	75,000	33.58	$2,518,500.00	5,023,447	4
2025-02-19	Stephenson, Brian C	Officer	Secretary, Treasurer & CFO	Direct	Sale	4,148	36.16	$149,991.68	102,464	4
2025-02-19	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	31,543	36.35	$1,146,588.05	211,718	4
2025-01-31	Viking, Global Opportunit…	TenPercentOwner	-	Indirect	Sale	3,065,616	34.90	$106,989,998.40	22,055,375	4
2025-01-29	Kumar, Neil	Director,Officer	Chief Executive Officer	Indirect	Sale	273,068	36.58	$9,988,827.44	5,098,447	4
2025-01-28	Stephenson, Brian C	Officer	Secretary, Treasurer & CFO	Direct	Sale	68,000	36.29	$2,467,720.00	93,758	4
2024-11-19	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	27,389	22.58	$618,443.62	4,897,443	4
2024-11-19	Stephenson, Brian C	Officer	Secretary, Treasurer & CFO	Direct	Sale	4,156	22.41	$93,135.96	93,758	4
2024-09-13	Kkr, & Co. Inc., Kkr Grou…	TenPercentOwner	-	Indirect	Sale	5,800,000	25.75	$149,350,000.00	25,260,971	4
2024-08-19	Kumar, Neil	Director,Officer	Chief Executive Officer	Direct	Sale	27,389	24.76	$678,151.64	4,897,443	4
2024-08-19	Stephenson, Brian C	Officer	Secretary, Treasurer & CFO	Direct	Sale	4,155	24.76	$102,877.80	85,192	4
2024-06-04	Scott, Randal W.	Director	-	Indirect	Sale	1,500	31.30	$46,950.00	4,000	4
2024-03-01	Scott, Randal W.	Director	-	Indirect	Sale	2,500	34.00	$85,000.00	6,500	4
2024-02-15	Valantine, Hannah	Director	-	Direct	Sale	2,915	37.75	$110,041.25	1,764	4
2024-01-16	Valantine, Hannah	Director	-	Direct	Sale	2,915	37.97	$110,682.55	1,764	4
2023-12-26	Mccormick, Frank	Director	-	Indirect	Sale	100,000	42.06	$4,206,000.00	627,689	4
2023-12-18	Scott, Randal W.	Director	-	Indirect	Sale	2,000	40.00	$80,000.00	9,000	4
2023-12-15	Valantine, Hannah	Director	-	Direct	Sale	2,915	36.12	$105,289.80	1,764	4
2023-12-01	Scott, Randal W.	Director	-	Indirect	Sale	2,500	29.25	$73,125.00	11,000	4
2023-11-17	Stephenson, Brian C	Officer	Secretary, Treasurer & CFO	Direct	Sale	22,685	29.10	$660,133.50	36,710	4
2023-11-17	Kumar, Neil	Director,Officer	CEO and President	Direct	Sale	51,552	29.33	$1,512,020.16	4,813,197	4
2023-11-15	Valantine, Hannah	Director	-	Direct	Sale	2,915	30.00	$87,450.00	1,764	4
2023-09-05	Scott, Randal W.	Director	-	Indirect	Sale	2,500	30.00	$75,000.00	13,500	4
2023-08-17	Stephenson, Brian C	Officer	Secretary, Treasurer & CFO	Direct	Sale	22,683	28.59	$648,506.97	36,710	4
2023-08-17	Kumar, Neil	Director,Officer	CEO and President	Direct	Sale	51,552	28.59	$1,473,871.68	4,813,197	4
2023-07-18	Viking, Global Opportunit…	TenPercentOwner	-	Indirect	Sale	1,500,000	35.00	$52,500,000.00	25,120,991	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

95.53%

Inst. Shares: 186,080,680

Shares Outstanding: 194,789,897

2025-12-31

95.60%

Inst. Shares: 183,106,081

Shares Outstanding: 191,527,482

2025-09-30

94.11%

Inst. Shares: 180,561,956

Shares Outstanding: 191,854,152

2025-06-30

97.11%

Inst. Shares: 185,015,202

Shares Outstanding: 190,517,215

2025-03-31

95.72%

Inst. Shares: 182,002,755

Shares Outstanding: 190,145,253

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	186,080,680	194,789,897	95.53%
2025-12-31	183,106,081	191,527,482	95.60%
2025-09-30	180,561,956	191,854,152	94.11%
2025-06-30	185,015,202	190,517,215	97.11%
2025-03-31	182,002,755	190,145,253	95.72%
2024-12-31	174,877,925	186,075,873	93.98%
2024-09-30	169,351,767	188,510,372	89.84%
2024-06-30	172,635,185	187,586,680	92.03%
2024-03-31	164,457,255	178,705,310	92.03%
2023-12-31	159,080,698	162,791,511	97.72%
2023-09-30	157,017,130	163,308,632	96.15%
2023-06-30	147,906,123	160,535,435	92.13%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BridgeBio Pharma, Inc. (BBIO) — SEC Financial Statements & Analysis

BridgeBio Pharma, Inc. (BBIO) is a pharmaceutical preparations company, incorporated in DE. BridgeBio Pharma, Inc. trades on Nasdaq as: BBIO. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BridgeBio Pharma, Inc. reported a 355.17% year-over-year revenue growth, a Gross Profit Margin of 95.13% (TTM), a Debt-to-Equity ratio of -1.60x, a Price-to-Sales (P/S) ratio of 24.94x (TTM), a Price-to-Book (P/B) ratio of -6.38 (TTM), at a market cap of $14.47B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 355.17%
Gross Profit Margin TTM: 95.13%
Debt To Equity: -1.60x
P/S TTM: 24.94x
P/B TTM: -6.38
Market Cap: $14.47B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BridgeBio Pharma, Inc. in?

BridgeBio Pharma, Inc. (BBIO) operates in the Pharmaceutical Preparations industry.

What is BBIO's market cap?

BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $14.47B as of 2026-03-31.

What exchange does BBIO trade on?

BridgeBio Pharma, Inc. (BBIO) trades on the Nasdaq.

Where is BridgeBio Pharma, Inc. incorporated?

BridgeBio Pharma, Inc. is incorporated in DE.

BridgeBio Pharma, Inc. (BBIO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.